Adler Group S.A. ADLER GROUP SA/ LU1250154413 /
2024-03-28 11:57:12 AM | Chg. -0.0020 | Volume | Bid2024-03-28 | Ask2024-03-28 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.1810EUR | -1.09% | 2,610 Turnover: 192.1935 |
0.1661Bid Size: 100,000 | 0.1961Ask Size: 100,000 | 21.25 mill.EUR | 176.99% | - |
GlobeNewswire
03-14
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Tria...
GlobeNewswire
03-13
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromya...
GlobeNewswire
03-12
Flexera 2024 State of the Cloud: Managing Cloud Spending is the Top Challenge of Cloud Computing, wh...
GlobeNewswire
03-08
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spect...
GlobeNewswire
03-06
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
GlobeNewswire
02-29
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dos...
GlobeNewswire
02-20
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Cl...
GlobeNewswire
02-05
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
GlobeNewswire
01-29
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children...
Newsfile Corp
01-24
Whiskey Wise Group Launches an AI-driven App, Redefining the Landscape of Whiskey Casks in 2023.
GlobeNewswire
2023-12-21
Pomerantz LLP and Wolf Haldenstein Adler Freeman & Herz LLP Announce Proposed Class Action Settlemen...
GlobeNewswire
2023-12-01
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
GlobeNewswire
2023-11-28
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Pro...
GlobeNewswire
2023-11-24
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
GlobeNewswire
2023-10-31
SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain M...
GlobeNewswire
2023-10-10
BridgeBio Pharma Announces New England Journal of Medicine Publication of Positive Encaleret Proof-o...
GlobeNewswire
2023-09-29
SciSparc Initiated Its Clinical Trial with SCI-210 in Pediatrics with Autism Spectrum Disorder